Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
Watowichs research group at the University of Texas Medical Branch (UTMB) at Galveston as a selective inhibitor of the metabolic enzyme nicotinamide N-methyltransferase (NNMT)
Toxicological effects of secondary air pollutants
To work properly in the second step, 5-LOX requires the presence of two accessory proteins embedded in the membrane - fivelipoxygenase activating protein (FLAP) and coactosin-like protein (CLP)
PMID 11373322
Periodic treatment breaks are commonly recommended to prevent receptor adaptation and ensure continued responsiveness
US$ 29.81
US$ 26.25
US$ 27.83
